U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07418372) titled 'Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine' on Feb. 11.
Brief Summary: This is a randomized, double-blinded, parallel-controlled phase I/II clinical trial to evaluate the safety and preliminary immunogenicity of the Tetanus, Diphtheria and Acellular Component Pertussis Vaccine Adsorbed (reduced antigen content) in subjects aged 6 years and above.
Study Start Date: March 12
Study Type: INTERVENTIONAL
Condition:
Tetanus, Diphtheria and Acellular Pertussis Vaccination
Tetanus
Diphtheria
Pertussis
Pertussis Vaccines
Intervention:
BIOLOGICAL: low-dose Tetanus, Diphtheria and Acellular Component...